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Abstract
Background: The mitotic exit network (MEN) is required for events at the end of mitosis such
as degradation of mitotic cyclins and cytokinesis. Bub2 and its binding partner Bfa1 act as a GTPase
activating protein (GAP) to negatively regulate the MEN GTPase Tem1. The Bub2/Bfa1 checkpoint
pathway is required to delay the cell cycle in response to mispositioned spindles. In addition to its
role in mitotic exit, Tem1 is required for actomyosin ring contraction.
Results: To test the hypothesis that the Bub2 pathway prevents premature actin ring assembly,
we compared the timing of actin ring formation in wild type, bub2Δ, mad2Δ, and bub2Δmad2Δ cells
both with and without microtubules. There was no difference in the timing of actin ring formation
between wild type and mutant cells in a synchronized cell cycle. In the presence of nocodazole,
both bub2Δ and mad2Δ cells formed rings after a delay of the same duration. Double mutant
bub2Δmad2Δ and bfa1Δmad2Δ cells formed rings at the same time with and without nocodazole.
To determine if Bub2 has an effect on actomyosin ring contraction through its regulation of Tem1,
we used live cell imaging of Myo1-GFP in a bub2Δ strain. We found a significant decrease in the
total time of contraction and an increase in rate of contraction compared to wild type cells. We
also examined myosin contraction using Myo1-GFP in cells overexpressing an epitope tagged Bub2.
Surprisingly, overexpression of Bub2 also led to a significant increase in the rate of contraction, as
well as morphological defects. The chained cell phenotype caused by Bub2 overexpression could
be rescued by co-overexpression of Tem1, and was not rescued by deletion of BFA1.
Conclusion: Our data indicate that the Bub2 checkpoint pathway does not have a specific role in
delaying actin ring formation. The observed increase in the rate of myosin contraction in the bub2Δ
strain provides evidence that the MEN regulates actomyosin ring contraction. Our data suggest
that the overexpression of the Bub2 fusion protein acts as a dominant negative, leading to septation
defects by a mechanism that is Tem1-dependent.

Background
The coordination of multiple events during M phase is
essential for accurate chromosome segregation. Mitotic
checkpoints ensure that chromosomes and the spindle are

correctly aligned, and mitotic kinase activity prevents
cytokinesis from occurring before mitosis is completed.
Budding yeast is an excellent model system to study the
complex regulation that couples mitotic exit with the
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onset of actomyosin ring contraction to complete cell
division.
The mitotic checkpoint in budding yeast has two separate
pathways, one for sensing kinetochore attachment to
microtubules, and another for sensing spindle position
[1]. The first pathway requires a number of known genes,
including MAD2, and acts to prevent the metaphase to
anaphase transition [2]. The second pathway relies on the
Bub2/Bfa1 complex to inhibit mitotic exit [3-6]. Both
pathways must be intact for complete arrest of the cell
cycle in mitosis in response to microtubule depolymerization, as deletion of genes in a single pathway results in a
cell cycle delay after which cells exit mitosis [3-6].
The spindle orientation pathway inhibits exit from mitosis through negative regulation of the mitotic exit network
(MEN) [4]. Tem1, a small GTPase at the top of the pathway, is activated by its GEF Lte1, and inactivated by the
two part GAP Bub2/Bfa1 [7-9]. The MEN regulates both
mitotic exit and the onset of cytokinesis and septation.
MEN activation leads to mitotic cyclin degradation, and
the inactivation of mitotic kinase activity is required for
cytokinesis [10,11]. In addition, some MEN proteins
localize to the bud neck at the time of cytokinesis, and
Tem1 has been shown to be required for myosin contraction [12-16]. Examination of actin ring formation in
apc2–8 mutants with and without a BUB2 deletion led to
the hypothesis that the Bub2 pathway acts to prevent premature actin ring formation [17,18]. This model predicts
that bub2Δ cells will form actin rings earlier than BUB2
cells under conditions where the Bub2 checkpoint pathway is normally activated. It has also been proposed that
Bub2 acts every cell cycle to restrain Tem1 activity until
the end of mitosis [18], in which case even unperturbed
cells lacking Bub2 may show premature actin ring formation. Here, we test these hypotheses by examining actin
ring formation in synchronized cells with and without
nocodazole to depolymerize microtubules and cause
checkpoint activation. We found no evidence that the
Bub2 checkpoint pathway acts to prevent premature actin
ring formation, but we did see an effect on myosin contraction in bub2Δ cells, as well as a septation defect in cells
overexpressing a dominant negative Bub2.

Results
The Bub2 checkpoint pathway does not regulate actin ring
formation
Previous studies showed that deletion of BUB2 led to
MEN dependent actin ring formation in an apc2–8 mutant
at the non-permissive temperature [17,18]. This led to the
hypothesis that the Bub2 branch of the spindle assembly
checkpoint specifically prevents premature actin ring formation. To test this idea, we looked at the timing of actin
ring assembly in synchronized cells. Wild-type, bub2Δ,
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mad2Δ, and bub2Δmad2Δ cells were arrested in G1 using
α-mating factor. After release from the arrest, cells were
fixed at 10-minute intervals as they progressed through
the cell cycle and stained for actin filaments. As shown in
Figure 1A, actin ring formation peaked 80 minutes after
release from G1 arrest in all strains. Therefore, deletion of
BUB2 did not noticeably affect the timing of actin ring formation in a normal cell cycle.
We next examined actin ring formation after perturbation
of the cell cycle using nocodazole, a drug that causes
microtubule disassembly. As before, wild-type, bub2Δ,
mad2Δ, and bub2Δmad2Δ cells were arrested in G1 using
α-mating factor. Cells were released from the arrest into
media containing 15 μg/ml nocodazole, fixed at 10minute intervals, and stained for actin filaments. As
expected, wild type cells did not form an actin ring due to
cell cycle arrest (Figure 1C). Cells lacking either BUB2 or
MAD2 formed actin rings with the same kinetics, with
actin rings peaking at 140 minutes after release from G1
arrest (Figure 1C). The delay in actin ring formation in
these strains relative to untreated cells is consistent with
the cell cycle delay caused by loss of one of the two spindle damage checkpoints [3-6]. Double mutant
bub2Δmad2Δ cells had peak actin ring formation at 80
minutes (Figure 1C), the same as unperturbed cells (Figure 1A), consistent with the complete loss of mitotic spindle checkpoints in the double mutant.
Our data show that actin ring formation in the presence of
nocodazole occurs at the same time in bub2Δ cells as
mad2Δ cells. Additionally, bub2Δmad2Δ cells form rings at
the same time with or without microtubules. Therefore,
Bub2 does not specifically restrain actin ring formation in
response to spindle damage.
Bfa1 does not show a Bub2 independent effect on actin
ring formation
It has been proposed that Bfa1 has Bub2 independent
functions, as overexpression of Bfa1 causes mitotic arrest
even in the absence of Bub2 [6,19]. Therefore, we analyzed actin ring formation in synchronized bub2Δbfa1Δ
and mad2Δbfa1Δ cells with and without nocodazole to see
if deletion of BFA1 had an additional effect. In unperturbed cells, actin ring formation peaked at 80 minutes in
wild type controls as well as bub2Δbfa1Δ and mad2Δbfa1Δ
cells, the same as in bub2Δ and mad2Δ cells (Figure 1A and
1B). In nocodazole, bub2Δbfa1Δ cells had a peak of actin
ring formation at 140 minutes, the same as in bub2Δ cells
(Figure 1C and 1D). Nocodazole treated mad2Δbfa1Δ cells
had a peak of actin ring formation at 80 minutes, similar
to mad2Δbub2Δ cells in nocodazole and untreated cells
(Figure 1C and 1D). Therefore, we found no evidence for
Bfa1 having a Bub2 independent effect on actin ring formation.
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Figure
The
Bub2
1 checkpoint pathway does not regulate actin ring formation
The Bub2 checkpoint pathway does not regulate actin ring formation. A. and B. Actin ring formation in synchronized
cells. Isogenic wild type (KSY3), bub2Δ (KSY19), bub2Δmad2Δ (KSY47), mad2Δ (KSY51), bub2Δbfa1Δ (KSY110) and
mad2Δbfa1Δ (KSY111) strains were arrested in G1 with α mating factor, released from arrest and fixed at regular intervals
during mitosis. Cells were stained for actin with Alexa 586 phalloidin and ≥ 300 cells were examined microscopically at each
time point to calculate the percentage of cells with an actin ring. Reproducible results were obtained in three independent
experiments, and representative results from a single experiment are shown. C. and D. Actin ring formation in nocodazole.
The same strains as in A. and B. were treated as above, except for the addition of nocodazole at release from α mating factor
(time 0).

The rate of myosin contraction is affected by Bub2
Previous studies have suggested that the MEN regulates
actomyosin ring contraction [14]. To test this hypothesis,
we examined myosin contraction using Myo1-GFP in
bub2Δ cells and compared myosin dynamics in bub2Δ cells
to wild type and mad2Δ. Cells expressing Myo1-GFP were
filmed at one-minute intervals on agarose pads and ana-

lyzed as described in Methods. Cells had a band of Myo1GFP fluorescence across the bud neck that began to
decrease in size at the onset of cytokinesis (Figure 2). The
total time of contraction was measured from the time
when the Myo1-GFP band began to decrease in size until
Myo1-GFP was no longer visible at the bud neck (Figure 2
and Table 1). For wild type cells, the time of contraction

Page 3 of 12
(page number not for citation purposes)

BMC Cell Biology 2009, 10:43

http://www.biomedcentral.com/1471-2121/10/43

Table 1: Deletion and overexpression of Bub2 increase the rate of myosin contraction.

Average size bud neck in μm +/
- stdev

Average time of contraction in
min +/- stdev

wild type KSY70

1.3 +/- 0.2

8.1 +/- 0.9

bub2Δ
KSY71

1.3 +/- 0.2

5.9 +/- 1.3

0.004

0.23 +/- .05

0.01

7

mad2Δ
KSY73

1.3 +/- .06

10.1 +/- 3.5

0.3

0.14 +/- .08

0.5

4

Bub2 OE
KSY132

1.3 +/- .09

6.3 +/- 0.5

0.001

0.21 +/- .02

0.03

7

Strain

was an average of 8.1 min (+/- 0.9), consistent with previously published results (Table 1, Figure 2A, and Additional File 1) [20,21]. Deletion of BUB2 resulted in a more
rapid contraction, 5.9 min (+/- 1.3), (P < .005, Table 1,
Figure 2B, and Additional File 2). In contrast, deletion of
MAD2 resulted in a slightly slower average time of Myo1GFP contraction, 10.1 min (+/- 3.5), although this difference was not significantly different from wild type (Table
1). We also calculated the average rate of contraction by
measuring the width of the bud neck and dividing by the
time of contraction. Deletion of BUB2 resulted in a significantly increased rate, 0.23 μm/min, compared to 0.16
μm/min in wild type cells (Table 1). The rapid contraction
of the Myo1-GFP ring in bub2Δ cells prevented the observation of a clear "dot" of myosin signal normally seen at
the bud neck at the end of cytokinesis (Figure 2). Analysis
of fluorescence intensity profiles indicated that the Myo1GFP signal ingressed equally from both sides without a
loss of intensity. Overall, this data shows that the Bub2

P value

Average rate of contraction μm/
min +/- stdev

P value N

0.16 +/- .04

7

checkpoint pathway has an effect on the timing of actomyosin ring contraction, while the Mad2 branch of the
pathway does not.
Bub2 overexpression affects myosin contraction and
causes septation defects
Since bub2Δ caused an increase in the rate of contraction,
we wanted to determine if overexpression of Bub2 would
slow contraction. Bub2 tagged at the N terminus with T7
and at the C terminus with 6His under control of the
inducible GAL1 promoter [19] was integrated into wild
type cells expressing Myo1-GFP. These cells were grown in
YPR, and then arrested in G1 with α factor with the addition of galactose for three hours to induce Bub2 expression. After release from G1 arrest, Myo1-GFP images were
captured as cells underwent cytokinesis. Unexpectedly,
Bub2 overexpression increased the speed and rate of
Myo1 contraction similar to bub2Δ (Table 1). This result
could be due to the overexpressed Bub2, which is tagged

Figure 2of Bub2 decreases the time of myosin contraction
Deletion
Deletion of Bub2 decreases the time of myosin contraction. A. Wild type cells expressing Myo1-GFP (KSY70) show
contraction of myosin over 10 minutes. B. bub2Δ cells expressing Myo1-GFP (KSY71) show contraction of myosin over 4 minutes. The asterisk indicates the frame (T = 0) after which contraction is evident. Images in the series were taken at one-minute
intervals.
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with T7 and 6His, acting as a dominant negative. See
Additional file 3 for a time-lapse image of Myo1-GFP following Bub2 overexpression.
We further investigated the effects of T7-Bub2-6His overexpression by comparing cells with the GAL1-T7-Bub26His construct grown in conditions to repress (YPD) or
induce (YPGR) expression. All strains showed a similar
level of Bub2 protein expression when grown in YPGR
(Figure 3C). As shown previously, cells exhibited slower
growth on YPGR plates compared to YPD [19]. The slow
growth was evident even in bub2Δ and bfa1Δ backgrounds
(Figure 3A and 3B). This growth defect was rescued by cooverexpression of Tem1 using the GAL1 promoter (Figure

Figure 3
Overexpression
of a Bub2 construct slows growth
Overexpression of a Bub2 construct slows growth. A.
Cells grown on YPD at 30°C for two days. B. Cells grown on
YPGR at 30°C for two days. 1.) wild type (KSY3), 2.) wild
type with GAL1-BUB2 (KSY129), 3.) bub2Δ with GAL1BUB2 (KSY130), 4.) bfa1Δ with GAL1-BUB2 (KSY169) 5.)
wild type with GAL1-Tem1 and GAL1-Bub2 (KSY171). C.
GAL1-T7-Bub2-6His is expressed in galactose and repressed
in glucose. Anti-T7 blot of protein extracts lane 1: wild type
with GAL1-BUB2 (KSY129) grown in YPD, lane 2: wild type
with GAL1-BUB2 (KSY129) grown in YPGR, lane 3: bub2Δ
with GAL1-BUB2 (KSY130) grown in YPD, lane 4: bub2Δ
with GAL1-BUB2 (KSY130) grown in YPGR, lane 5: bfa1Δ
with GAL1-BUB2 (KSY169) grown in YPD, lane 6: bfa1Δ
with GAL1-BUB2 (KSY169) grown in YPGR. D. Expression
of GAL1-TEM induced by galactose and repressed by glucose. Anti-myc blot of protein extracts lane 1: GAL1-Tem1
GAL1-Bub2 (KSY171) in YPD, lane 2: GAL1-Tem1 GAL1Bub2 (KSY171) in YPGR.

http://www.biomedcentral.com/1471-2121/10/43

3A, B, and 3D). These data support the idea that the T7Bub2-6His acts as a dominant negative.
The overexpression of this Bub2 construct has been
reported to cause a cytokinesis defect, although the data
was not shown [19]. To study this effect more closely, we
determined effects on cell morphology by examining cells
grown in YPD or YPGR with and without zymolase treatment to remove the cell wall. In a wild type background,
cells with the GAL1-T7-Bub2-6His construct grown on
YPD had a very low incidence of the chain phenotype,
defined as three or more cell bodies (Figure 4). After
induction of Bub2 overexpression, an average of 53% of
cells exhibited the chained phenotype (Figure 4). After
treatment with zymolase, the chains were reduced to 42%
on average (Figure 4). In support of the idea that GAL1T7-Bub2-6His acts in a dominant negative fashion, the
effect of overexpression was similar in a bub2Δ strain,
with 55.5% of bub2Δ cells exhibiting a chain phenotype
before zymolase, and 43% after zymolase treatment (Figure 4). If the epitope-tagged Bub2 were acting the same as
endogenous Bub2, one would expect the phenotype to be
relieved, rather than exacerbated, by deletion of BUB2.
This data also shows that deletion of BUB2 does not cause
a cytokinesis or septation defect, as wild type cells and
bub2Δ cells had similar numbers of chained cells on YPD
(Figure 4). Unlike the previous report [19], we did not
find that deletion of BFA1 rescued the chain phenotype
(Figure 4). The morphological defects were rescued by cooverexpression of Tem1, which reduced the percentage of
chained cells in YPGR to similar levels as in YPD (Figure
4). Together, our data shows that overexpression of a T7Bub2-6His fusion protein acts as a dominant negative,
causing a chained cell phenotype that can be rescued by
Tem1 overexpression. The results of the zymolase assay
suggest that overexpression of Bub2 caused both a cytokinesis and a septation defect.
Because the percentage of chains caused by Bub2 overexpression decreased about 10% in zymolase, we examined
plasma membrane and cell wall formation after Bub2
overexpression. The plasma membrane was visualized
using FM 4–64, and the cell wall was stained using Calcofluor. Examination of chains with three of four cell bodies, formed after eight hours of Bub2 overexpression,
showed that chains typically had plasma membrane
across some bud necks, but not others (Figure 5A). In contrast, these chains showed a complete lack of cell wall formation at all bud necks (Figure 5C). This result was
surprising, since the zymolase assay (Figure 4) suggested
greater defects in cytokinesis than septation. Therefore, we
repeated the analysis after fifteen hours in YPGR. Most
bud necks showed plasma membrane formation between
cell bodies, although in some cases the plasma membrane
had abnormal bright dots or clumps at the bud neck (Fig-
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Figure
Bub2
overexpression
4
causes cytokinesis and septation defects that are rescued by co-overexpression of Tem1
Bub2 overexpression causes cytokinesis and septation defects that are rescued by co-overexpression of Tem1.
Cells were grown overnight (15 hours) in YPD or YPGR, then fixed. Strains used were: GAL1-BUB2 (KSY 129), GAL1-BUB2
bub2Δ (KSY130), GAL1-BUB2 bfa1Δ (KSY169), and GAL1-Bub2 GAL1-Tem1 (KSY171). Cells with (+ zym) and without zymolase treatment were examined under a microscope and the percentage of cells with chains (3 or more cell bodies) was calculated. Results shown are an average of three independent experiments, and error bars represent the standard deviation. 200
cells were counted for each treatment.
ure 5B). Only the buds at the end of the chains did not
have plasma membrane, consistent with being the most
recently formed buds. Cell wall formation looked very different after the longer Bub2 induction, with most bud
necks now showing septum formation, although in many
cases the septa seemed thicker and brighter than normal
(Figure 5D). These results suggest that overexpression of
the dominant negative Bub2 causes primary septum formation to fail, but over time cells may be able to separate
by forming an abnormal secondary septum (see Discussion).

inconsistent with data showing that Tem1, the target of
Bub2 regulation, is not required for actin ring formation
[14].
Our examination of actin ring formation in bub2Δ and
bfa1Δ strains shows that actin ring formation occurs with
normal kinetics in the absence of the Bub2 checkpoint.
Although it is possible that Bub2 or Bfa1 has a subtle
effect on actin ring formation that was missed by the 10
minute intervals used to examine the cells, this seems
unlikely, as our data is consistent with previous results
showing that bub2Δ does not advance anaphase onset [5].

Discussion
Regulation of actin ring formation
The MEN pathway in budding yeast regulates cytokinesis
as well as exit from mitosis. However, how the MEN controls cytokinesis is not understood. Experimental evidence
that actin rings form in apc2–8 bub2Δ cells suggested that
the Bub2 checkpoint pathway prevents premature actin
ring formation [17,18]. However, this hypothesis is

Bub2 and Mad2 are required for two separate branches of
the mitotic spindle checkpoint in budding yeast. Our data
show that cells lacking either one of these checkpoint
pathways form actin rings with the same kinetics after
nocodazole treatment. Therefore, the delay in actin ring
formation in bud2Δ and mad2Δ cells is caused by a cell
cycle delay. The actin rings seen in apc2–8 bub2Δ cells
Page 6 of 12
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phase, when MEN mutants arrest, is required for actin ring
formation, but there is no evidence that the MEN regulates actin ring formation directly.
Our data also do not support a Bub2 independent function of Bfa1 in actin ring formation. There was no apparent difference in the timing of actin ring formation in
unperturbed or nocodazole treated cells in isogenic
strains with and without a BFA1 deletion.
The MEN and actomyosin ring contraction
One way the MEN may act to regulate cytokinesis is to
trigger the onset of myosin contraction. Our data show
that deletion of BUB2 or overexpression of a dominant
negative Bub2 decreases the total time for contraction of
the myosin ring and increases the rate of contraction. This
effect on myosin contraction could either be due to direct
regulation of contraction by the MEN or an indirect effect
caused by defects in primary septum formation. Previous
studies have shown that preventing primary septum synthesis results in a cytokinesis failure due to premature
breaking and disassembly of the actomyosin ring [22,23].

Figure
Bub2
overexpression
5
causes a defect in cell wall formation
Bub2 overexpression causes a defect in cell wall formation. Wild type cells with GAL1-BUB2 (KSY 129) were
grown in YPGR for eight (A. and C.) or fifteen (B. and C.)
hours. A. and B. FM4-64 staining to visualize the plasma
membrane. Arrow points to closed bud necks. Arrowhead
points to abnormal plasma membrane at the bud neck. C.
Calcofluor staining shows lack of septum between buds in
chains. D. Calcofluor staining shows abnormal septum formation after longer incubation in YPGR (arrowhead). Images are
a single plane from a Z series and represent open or closed
bud necks as determined from examination of all planes of
the series. Scale bar = 5 μm.

[17,18] are likely due to loss of cell cycle arrest and subsequent downstream events such as actin ring formation. In
fact, the authors noted that apc2–8 cells remained arrested
in mitosis, while apc2–8 bub2Δ cells exited mitosis after
two hours [18]. Therefore, progression through late ana-

We do not think our results are due to indirect effects of
septation defects for two reasons. Firstly, we did not see
any evidence of abnormal or asymmetrical contraction in
bub2Δ or GAL1-T7-Bub2-6His cells, which would be predicted by this model. Secondly, bub2Δ cells showed no
evidence of a defect in primary septum formation, yet still
exhibited the myosin contraction phenotype. Our results
suggest that MEN activation directly influences either the
onset or the rate of myosin contraction, and that the Bub2
checkpoint pathway acts as a brake on actomyosin ring
contraction. This model is also supported by previous
results showing that Tem1 and Mob1 are required for
actomyosin ring contraction when the requirement for
MEN function in mitotic exit is bypassed [14,24]. The
MEN therefore has a role in promoting cytokinesis that is
separate from its role in mitotic kinase inactivation. In
contrast, the role of the MEN in promoting primary septum formation depends only on exit from mitosis [25].
The identification of MEN targets involved in the regulation of actomyosin ring contraction will be of great interest. Potential targets include Iqg1, which has been shown
to interact with Tem1 in vitro, and Hof1, which is phosphorylated in a MEN-dependent manner [26,27].
Dominant negative effects of Bub2 overexpression
The GAL1-T7-Bub2-6His construct used in this study has
been previously described as partially inhibiting cell
growth only in the presence of Bfa1 [19]. It was also
reported to cause a chained cell phenotype, although this
data was not shown. We have confirmed that this construct causes a mild growth defect as well as a chain phenotype on galactose-containing media in our strain
background. However, we did not find that deletion of
Page 7 of 12
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BFA1 rescued either the growth defect or the chain morphology caused by overexpression of the Bub2 fusion protein. We have further examined the chained cell
phenotype, and found evidence for the presence of both
cytokinesis and septation defects.
We obtained this construct in the hopes that overexpressing Bub2 would decrease the rate of myosin contraction,
since deletion of Bub2 increased the rate. However, we
found similar rates of Myo1-GFP contraction in cells
expressing T7-Bub2-6His and bub2Δ cells. This is most
likely due to the T7-Bub2-6His acting as a dominant negative that interferes with normal Tem1 function. Supporting this conclusion, overexpression of an untagged Bub2
using the GAL1 promoter does not result in a growth
defect [28]. Interestingly, overexpression of Bfa1 has a different phenotype than overexpression of either untagged
or dominant negative Bub2. Bfa1 overexpression arrests
cells in mitosis, and this arrest does not require Bub2
[6,19].
Causes of cytokinesis and septation defects
Interestingly, we did not observe a correlation between
increased rates of myosin contraction and cytokinesis or
septation defects. Deletion of BUB2 or overexpression of
Bub2 had a similar effect on Myo1-GFP dynamics, but
only Bub2 overexpression resulted in the chained cell
phenotype. Therefore, the significantly increased rate of
myosin contraction we observed does not have an effect
on cell morphology under normal growth conditions.

How then does overexpression of a dominant negative
Bub2 cause morphological defects? Our data suggest that
the T7-Bub2-6His must be affecting Tem1 in a way that
does not prevent exit from mitosis, but perturbs septum
formation. A temperature sensitive mutant of the MEN
kinase Cdc15, cdc15-2, has been shown to have a septation defect when grown at the semipermissive temperature (31°C) [13]. Since binding of Cdc15 to Tem1 is
required for Cdc15 activation and prevented by Bub2/
Bfa1, the interaction of Cdc15 with Tem1 could be partly
inhibited by T7-Bub2-6His overexpression [29,30].
Zymolase treatment of cells after fifteen hours of Bub2
overexpression resulted in approximately 10% fewer
chains than without zymolase, suggesting that some of
the chains were due to septation failure, and most of the
chains were due to cytokinesis failure. However, staining
of plasma membrane and cell wall structures at earlier
timepoints showed that lack of septum formation was the
primary defect (Figure 5C). Staining at later timepoints
indicated that many of the bud necks in the chains had
become separated by plasma membrane and chitin, some
of which appeared abnormal (Figure 5) and may represent the deposition of thick secondary septa that eventu-
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ally separate the cells, sometimes trapping pockets of
membrane within. Electron microscopy has shown that
yeast cells that fail cytokinesis due to lack of myosin and
those that fail to form the primary septum due to a lack of
chitin synthase have identical phenotypes [23]. In both
cases, the cells form a thick cell wall that lack the normal
trilaminar structure [23]. It is unclear whether or not
zymolase can efficiently digest this abnormally thick septum. Therefore, the zymolase assay may not be able to distinguish failure to contract an actomyosin ring from
failure to build a primary septum, since in both cases the
cells can eventually separate the plasma membrane by lateral thickening of the cell wall. Additionally, it has been
shown that preventing primary septum formation causes
instability of the actomyosin ring [22]. Therefore, the two
processes of cytokinesis and septation may be so closely
linked in budding yeast that defects in one process result
in problems in the other.
We think it is likely that the formation of chains of cells
after overexpression of a dominant negative Bub2 is
caused by a failure to form the primary septum, and that
these cells eventually form an abnormal septum as seen
previously by EM. The contradictory results from the
zymolase assay may be due to incomplete digestion of
these thick septal structures, failing to separate the
chained cell bodies even though they are separated by
plasma membrane. Together, our data suggest that the
Bub2 pathway, and therefore the MEN, regulates septation or the coordination of septation with actomyosin
ring contraction.

Conclusion
Deletion of BUB2 did not affect the timing of actin ring
assembly, but did increase the rate of myosin contraction.
Overexpression of a tagged Bub2 protein caused septation
defects that were rescued by Tem1 overexpression.
Together, the data suggest that the MEN regulates actomyosin ring contraction and septation.

Methods
Yeast media
Yeast cell culture and genetic techniques were carried out
by methods described [31]. Yeast cells were grown in YPD
medium (1% yeast extract, 2% Bacto peptone, 2% glucose), YPR (1% yeast extract, 2% Bacto peptone, 2% raffinose), or YPGR (1% yeast extract, 2% Bacto peptone, 2%
galactose, 2% raffinose) liquid medium, or on – HIS, LEU, -TRP or -URA drop-out solid and/or liquid medium
at 30°C.
Strain Construction
All S. cerevisiae strains were W303 background, derived
from KSY3 (MATa ura3-52 leu2-3,112 his3-Δ200 trp1-1
ade2 Δbar1). All yeast strains used for this study are listed
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in Table 2. To create Myo1-GFP expressing strains, pKT36
(MYO1 under its endogenous promoter tagged with GFP
on a TRP1 CEN plasmid) [14] was digested with AgeI
enzyme and transformed into KSY3, KSY19, KSY51, and
KSY129 strains to make KSY 70, 71, 73, and 132 respectively.
To create Bub2 over-expressing strains, pKT1315 (Ro et
al., 2001) was digested with NcoI and transformed into
KSY3, KSY19 and KSY167 to make KSY129, 130, and 169
respectively. To create the GAL1-myc-TEM1 strain
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KSY171, pKT25 (GAL1-myc-TEM1 on a LEU2 CEN plasmid) was cut with XcmI and transformed into KSY129.
Expression of Bub2 and Tem1 was verified by Western
Blot.
To make strains more sensitive to alpha mating factor, the
BAR1 locus was replaced by HIS3 or URA3 in strains
KSY21, KSY22, KSY24, and KSY25 using PCR-mediated
one-step gene replacement [32] using PRS313 or PRS316
as the template and primers as in [33] to make KSY110,
KSY111, KSY51, and KSY47 respectively.

Table 2: Strains used in this study. All strains are W303 background.

Strain Name Genotype

Source

KSY3

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbar1

Lippincott and Li, 1998 (RLY261)

KSY19

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbub2:LEU2 Δbar1

Li lab (RLY597)

KSY21

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbfa1: HIS3 Δbub2:LEU2

Li, 1999 (RLY684)

KSY22

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbfa1: HIS3 Δmad2:LEU2

Li, 1999 (RLY686)

KSY24

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δmad2:LEU2

Li, 1999 (RLY718)

KSY25

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbub2:LEU2 Δmad2:URA3

Li, 1999 (RLY736)

KSY47

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbub2:LEU2 Δmad2:URA3 Δbar1:HIS3

This work

KSY51

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δmad2:LEU2 Δbar1:HIS3

This work

KSY70

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbar1 MYO1-GFP: TRP1 (pKT36)

This work

KSY71

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbub2:LEU2 Δbar1 MYO1-GFP: TRP1 (pKT36)

This work

KSY73

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δmad2:LEU2 Δbar1:HIS3 MYO1-GFP: TRP1
(pKT36)

This work

KSY110

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbfa1: HIS3 Δbub2:LEU2 Δbar1:URA3

This work

KSY111

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbfa1: HIS3 Δmad2:LEU2 Δbar1:URA3

This work

KSY129

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbar1 GAL1-T7-BUB2-6His: URA3 (pKL1315)

This work

KSY130

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbub2:LEU2 Δbar1 GAL1-T7-BUB2-6His: URA3
(pKL1315)

This work

KSY132

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbar1 MYO1-GFP: TRP1 (pKT36) GAL1-T7-BUB26His: URA3 (pKL1315)

This work

KSY167

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbfa1: HIS3

Li, 1999 (RLY683)

KSY169

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbfa1: HIS3 GAL1-T7-BUB2-6His: URA3
(pKL1315)

This work

KSY171

MATa ura3–52 leu2–3,112 his3-Δ200 trp1-1 ade2 Δbar1 GAL1-T7-BUB2-6His: URA3 (pKL1315)
GAL1-myc-Tem1 (pKT25)

This work
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Yeast Transformation
Yeast transformations were performed by modified lithium acetate method [34]. After 30 minutes incubation at
30°C, 50 μl of DMSO was added and mixed. Cells were
plated on appropriate media and incubated at 30°C for
two-three days.
Fluorescence staining of Yeast Cells
KSY3, KSY19, KSY47, KSY51, KSY111 and KSY112 were
grown in YPD overnight. α-factor was added to a final
concentration of 100 ng/ml for 2 hours to synchronize
cells. Cells were washed with sterile dH2O three times and
resuspended in YPD or YPD with nocodazole (15 μg/ml
final). After release, cells were incubated at 30°C. Cells
released into YPD were incubated for 60 to 100 minutes,
during this period at every ten minutes, 5 ml of cells were
taken and fixed with 670 μl 37% formaldehyde for two
hours at room temperature. Cells released in YPD with
nocodazole were incubated for 60 to 240 minutes. At 60,
80, 100, 140, 180, 220 240 minutes time points, 5 ml of
cells were collected and fixed as above. Fixed cells were
stained with Alexa 568 (Invitogen) or rhodamine
(Cytoskeleton Inc. Denver, CO) phalloidin as described
[21].

Cells were observed using an Olympus IX51 inverted
microscope at 1,000× total magnification using a
UPLSAPO 100× NA 1.4 objective. A Texas-red filter
(Brightline) was used to view phalloidin staining. Images
were captured with a Hamamatsu ORCA285 CCD camera. Shutters, filters, and camera were controlled using
Slide Book software (Intelligent Imaging Innovations,
Denver, CO).
Time-lapse microscopy
Cells were grown overnight and placed on agarose pads
made by melting 0.2 g of agarose in 1 ml -TRP media [35].
Cells from strain KSY132 were grown overnight in YPR,
then arrested with alpha factor with galactose added to
2% final for three hours. Cells were washed 3× with sterile
water to release from arrest before imaging. Cells were
placed on the agarose pad and covered with cover slip
sealed with valap (1:1:1 mixture of Vaseline, lanolin, and
paraffin). Living cells were viewed using an Olympus IX51
inverted microscope at 1,000× total magnification using a
UPLSAPO 100× NA 1.4 objective. FITC (EX 482/35
506DM EM 536/40) filter was used to visualize GFP
(Brightline). Images were captured with a Hamamatsu
ORCA285 CCD camera. Shutters, filters, and camera were
controlled using Slide Book software (Intelligent Imaging
Innovations, Denver, CO). Images were collected with
exposure (100 ms to 200 ms) to fluorescent light at 1
minute intervals.

http://www.biomedcentral.com/1471-2121/10/43

Analysis of myosin contraction
To determine the onset of myosin contraction, the timelapse series of Myo1-GFP expressing cells was viewed at
200% magnification. Time zero was defined as the timepoint after which the ring decreased in diameter. The ruler
tool in Slidebook was used to measure the ring at T = 0
and the following frame to confirm that a change in diameter had occurred. A second blind analysis to determine
time zero was performed in order to eliminate observer
bias. Total time of contraction was the time elapsed
between time zero and when the Myo1-GFP signal disappeared from the bud neck. To determine the rate of contraction, the width of the bud neck was measured using
the ruler tool in Slidebook and divided by the total time
of contraction. Fluorescence intensity profiles were used
to examine symmetry of ring contraction. Excel was used
to calculate standard deviation and P-values using the
two-tailed T test.
Morphological Observations
Cultures of KSY129, 130, 169, and 171 were grown in YPR
overnight, then diluted into YPD and YPGR and grown for
fifteen hours at 30°C before addition of formaldehyde to
5% final. Fixed cells were treated both with and without
zymolyase before observing cells under the microscope
for phenotypic changes as described [21]. Morphology
was observed and cells were counted under Olympus
CH2, objective EA40 NA0.65.
Immunoblot Analysis
Cultures of KSY129, 130, 169, and 171 were grown in YPR
overnight, then diluted into either YPD or YPGR and
grown for three hours at 30°C before total yeast extracts
were prepared by glass bead lysis in SDS sample buffer.
Extracts were run on 4–20% Tris-Glycine gels (Invitrogen)
and transferred to nitrocellulose. T7-Bub2-6His was
detected using anti-T7 antibody diluted 1:1000 (Novagen), and myc-Tem1 was detected using anti-myc monoclonal antibody diluted 1:1000 (Covance). Donkey antimouse HRP conjugated secondary antibody was diluted
1:2500 (Jackson ImmunoResearch). The Pierce chemiluminescence detection kit was used (Thermo Scientific).
Comparable amounts of total protein were loaded in each
lane as shown by Coomassie staining of the same extracts
on a separate gel.
Plasma membrane and cell wall staining
To visualize the plasma membrane, FM4–64 (Invitrogen)
was added to cells in growth media on ice. For cell wall
staining, Calcofluor was used as described [36]. Calcofluor (Fluorescent brightener 28, Sigma) was added to
cells in growth medium to a final concentration of 100
μg/ml. Cells were incubated 5 minutes, washed twice with
H2O, and observed with a DAPI filter set.
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Additional material
Additional File 1
Myo1-GFP in wild type cell. This movie shows myosin contraction in the
cell shown in Figure 2A. The movie begins at asterisk in the figure, and
was taken at one-minute intervals.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712121-10-43-S1.mov]
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Additional File 2
Myo1-GFP in a bub2Δ cell. This movie shows myosin contraction in the
cell shown in Figure 2B. The movie begins at asterisk in the figure, and
was taken at one-minute intervals.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712121-10-43-S2.mov]
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Additional File 3
Myo1-GFP in a cell overexpressing Bub2. This movie shows myosin contraction in two cells after Bub2 induction by addition of galactose for three
hours. The movie was taken at one-minute intervals.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712121-10-43-S3.mov]
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